Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.

PloS One
Francis JacobViola Heinzelmann-Schwarz

Abstract

Activation of the Wnt signaling pathway is implicated in aberrant cellular proliferation in various cancers. In 40% of endometrioid ovarian cancers, constitutive activation of the pathway is due to oncogenic mutations in β-catenin or other inactivating mutations in key negative regulators. Secreted frizzled-related protein 4 (SFRP4) has been proposed to have inhibitory activity through binding and sequestering Wnt ligands. We performed RT-qPCR and Western-blotting in primary cultures and ovarian cell lines for SFRP4 and its key downstream regulators activated β-catenin, β-catenin and GSK3β. SFRP4 was then examined by immunohistochemistry in a cohort of 721 patients and due to its proposed secretory function, in plasma, presenting the first ELISA for SFRP4. SFRP4 was most highly expressed in tubal epithelium and decreased with malignant transformation, both on RNA and on protein level, where it was even more profound in the membrane fraction (p<0.0001). SFRP4 was expressed on the protein level in all histotypes of ovarian cancer but was decreased from borderline tumors to cancers and with loss of cellular differentiation. Loss of membrane expression was an independent predictor of poor survival in ovarian cancer patients (p = 0....Continue Reading

References

Jun 26, 1992·Cell·R Nusse, H E Varmus
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·K LinF P Luyten
Jan 16, 1999·Current Biology : CB·J J Loureiro
Nov 1, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·N Barker, H Clevers
Jan 17, 2002·The Journal of Pathology·Sze Chuen Cesar WongW L Wendy Hsiao
Jan 25, 2002·Genome Biology·Jeffrey R Miller
Apr 12, 2002·The American Journal of Pathology·Yali ZhaiKathleen R Cho
May 16, 2002·Journal of the National Cancer Institute·Willie Russell
Jun 28, 2002·Cancer Cell·Ashani T WeeraratnaJeffrey M Trent
Oct 1, 2003·The Journal of Pathology·Christoph WissmannChristian Pilarsky
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lisa G HorvathRobert L Sutherland
Mar 27, 2004·Cell Cycle·Jana HoffmanCalvin J Kuo
Jul 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Viola A Heinzelmann-SchwarzPhilippa M O'Brien
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anish BaliSusan M Henshall
Sep 17, 2004·Nature Reviews. Genetics·Randall T MoonAjamete Kaykas
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Lisa G HorvathRobert L Sutherland
Oct 9, 2004·Cancer Science·Toshio TakadaToshikazu Ushijima
Nov 24, 2004·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Nico JanssensAnnette Bakker
Aug 16, 2005·Cell Calcium·Aimee D Kohn, Randall T Moon
Mar 2, 2006·British Journal of Cancer·V A Heinzelmann-SchwarzP M O'Brien
May 18, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R AgarwalS B Kaye
Aug 29, 2007·Acta Pharmacologica Sinica·Yihui ShiDavid M Jablons
Oct 24, 2008·International Journal of Cancer. Journal International Du Cancer·Her-Young SuMu-Hsien Yu
Nov 4, 2008·BMC Bioinformatics·Samuel ArvidssonBernd Mueller-Roeber
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Caroline E FordTommy Andersson
Dec 4, 2009·Oncology Reports·Ying HuangHeping Yang
Feb 16, 2010·The American Journal of Surgical Pathology·Robert J Kurman, Ie-Ming Shih
Mar 23, 2011·Gynecologic Oncology·Francis JacobViola Heinzelmann-Schwarz
Apr 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei DaiRobert Brown
Aug 28, 2012·The Journal of Molecular Diagnostics : JMD·Yan JiaMingzhou Guo

❮ Previous
Next ❯

Citations

Feb 22, 2013·Reproduction, Fertility, and Development·Han GerritsJan A Gossen
Oct 16, 2013·Gynecologic Oncology·Rebecca C ArendDonald J Buchsbaum
Apr 3, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Stefan ZschiedrichGerd Walz
Nov 3, 2015·Biochemical and Biophysical Research Communications·Samir H BarghoutYangXin Fu
Jan 30, 2014·International Journal of Cancer. Journal International Du Cancer·Paul H van der HorstLeen J Blok
Apr 12, 2016·The International Journal of Biochemistry & Cell Biology·Sudha WarrierArun Dharmarajan
Dec 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Sebastian PohlArun Dharmarajan
Dec 10, 2013·Biochimica Et Biophysica Acta·Rohit SuranaAlan Prem Kumar
Jun 18, 2016·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Wendy J van ZuylenWilliam D Rawlinson
Mar 8, 2017·Nitric Oxide : Biology and Chemistry·Uttara SaranSuvro Chatterjee
Aug 17, 2014·Radiation Oncology·Mariola Fotin-MleczekStephan M Huber
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Othman Abdulla Al-ShabanahSalem Saleh Al-Rejaie
Jun 24, 2016·Molecular and Cellular Biochemistry·Archita Ghoshal, Siddhartha Sankar Ghosh
Oct 6, 2019·Journal of Cancer Research and Clinical Oncology·Céline MontavonAndré Fedier
Oct 17, 2019·Journal of Clinical Medicine·Miriam Teeuwssen, Riccardo Fodde

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
biopsies
electrophoresis
ELISA
hormone replacement therapy
transcription profiling

Software Mentioned

Access
PEROV
Quantity One
SAS

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Biochemical and Biophysical Research Communications
Noemi ReguartDavid M Jablons
The Journal of Thoracic and Cardiovascular Surgery
Jae KimDavid M Jablons
Biochemical and Biophysical Research Communications
Yu-Ching LinDavid M Jablons
© 2022 Meta ULC. All rights reserved